Market Cap | 2.03B | P/E | - | EPS this Y | 31.20% | Ern Qtrly Grth | - |
Income | -180.91M | Forward P/E | -20.90 | EPS next Y | 41.50% | 50D Avg Chg | 3.00% |
Sales | 540.28M | PEG | -0.44 | EPS past 5Y | - | 200D Avg Chg | 23.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | 12.00% | 52W High Chg | -10.00% |
Recommedations | 1.90 | Quick Ratio | 1.10 | Shares Outstanding | 140.46M | 52W Low Chg | 141.00% |
Insider Own | 26.93% | ROA | -12.67% | Shares Float | 100.76M | Beta | 1.40 |
Inst Own | 67.13% | ROE | -1,000.48% | Shares Shorted/Prior | 11.93M/12.68M | Price | 17.14 |
Gross Margin | 69.44% | Profit Margin | -33.48% | Avg. Volume | 1,246,875 | Target Price | 17.46 |
Oper. Margin | -22.72% | Earnings Date | Nov 4 | Volume | 722,282 | Change | -3.65% |
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec surface modifications, Calibrate PSX, and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold for ease of handling and better endplate-to-endplate contact; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Lake Street | Buy | Sep 3, 24 |
Canaccord Genuity | Buy | Aug 30, 24 |
Needham | Buy | Aug 22, 24 |
Piper Sandler | Overweight | Aug 1, 24 |
Stifel | Buy | Aug 1, 24 |
Wells Fargo | Overweight | Aug 1, 24 |
HC Wainwright & Co. | Buy | Aug 1, 24 |
Needham | Buy | Aug 1, 24 |
Canaccord Genuity | Buy | Jul 25, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Sponsel David | EVP, SALES EVP, SALES | Feb 01 | Sell | 16.47 | 36,620 | 603,131 | 639,918 | 02/05/24 |
Hunsaker Craig E | EVP, PEOPLE & CULTUR.. EVP, PEOPLE & CULTURE | Feb 01 | Sell | 16.46 | 39,056 | 642,862 | 1,266,069 | 02/05/24 |
Lish Scott | CHIEF OPERATING OFFI.. CHIEF OPERATING OFFICER | Feb 01 | Sell | 16.47 | 25,210 | 415,209 | 518,457 | 02/05/24 |
Sponsel David | EVP, SALES EVP, SALES | Dec 21 | Sell | 15 | 2,500 | 37,500 | 557,780 | 12/26/23 |
Miles Patrick | CEO CEO | Sep 25 | Sell | 12.66 | 179,375 | 2,270,888 | 5,452,736 | 09/27/23 |
Miles Patrick | CEO CEO | Sep 18 | Sell | 13.42 | 180,000 | 2,415,600 | 5,632,111 | 09/20/23 |
Bakst Evan | Director Director | Aug 23 | Sell | 14.92 | 8,700 | 129,804 | 1,089,038 | 08/24/23 |
Pritzker Jennifer N. | 10% Owner 10% Owner | Aug 08 | Buy | 15.11 | 5,750 | 86,882 | 6,000 | 08/10/23 |
Hunsaker Craig E | EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC | Jun 27 | Sell | 18 | 107,029 | 1,926,522 | 1,120,427 | 06/28/23 |
Segal Paul | Director Director | Jun 12 | Sell | 15.15 | 71,329 | 1,080,634 | 100,000 | 06/16/23 |
TULLIS JAMES L L | Director Director | May 17 | Option | 3.5 | 261,178 | 914,123 | 658,267 | 05/18/23 |
TULLIS JAMES L L | Director Director | May 15 | Option | 3.5 | 261,177 | 914,120 | 575,283 | 05/16/23 |
Hunsaker Craig E | EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC | May 15 | Sell | 15.29 | 58,238 | 890,459 | 1,227,456 | 05/16/23 |
Berkowitz Mortimer III | Director Director | May 12 | Option | 3.5 | 107,937 | 377,780 | 663,058 | 05/12/23 |
Miles Patrick | CEO CEO | May 10 | Option | 3.5 | 269,842 | 944,447 | 5,872,606 | 05/12/23 |
Segal Paul | 10% Owner 10% Owner | May 10 | Sell | 14.88 | 167,496 | 2,492,340 | 171,329 | 05/12/23 |
L-5 Healthcare Partners, LLC | 10% Owner 10% Owner | May 10 | Sell | 14.88 | 1,700,000 | 25,296,000 | 11,081,538 | 05/12/23 |
Hunsaker Craig E | EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC | Apr 24 | Sell | 15.85 | 28,311 | 448,729 | 1,285,694 | 04/24/23 |
Koning John Todd | CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER | Apr 20 | Sell | 16.42 | 16,500 | 270,930 | 415,552 | 04/24/23 |
Miles Patrick | CEO CEO | Apr 04 | Sell | 15.86 | 353 | 5,599 | 5,607,764 | 04/06/23 |
TULLIS JAMES L L | Director Director | Mar 08 | Sell | 16.12 | 30,000 | 483,600 | 467,974 | 03/09/23 |
WOODS WARD W JR | Director Director | Mar 06 | Option | 3.5 | 539,683 | 1,888,890 | 2,174,604 | 03/08/23 |
Miles Patrick | CEO CEO | Mar 06 | Sell | 5348.23 | 180,000 | 962,681,400 | 5,748,117 | 03/08/23 |
Hunsaker Craig E | EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC | Feb 27 | Sell | 15.23 | 126,033 | 1,919,483 | 1,346,828 | 03/01/23 |
Lish Scott | SVP, DEVELOPMENT SVP, DEVELOPMENT | Feb 27 | Option | 3.5 | 13,493 | 47,226 | 444,015 | 03/01/23 |
Lish Scott | SVP, DEVELOPMENT SVP, DEVELOPMENT | Feb 27 | Sell | 14.76 | 25,372 | 374,491 | 430,522 | 03/01/23 |
Koning John Todd | CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER | Feb 27 | Sell | 14.76 | 22,500 | 332,100 | 432,052 | 03/01/23 |
Koning John Todd | CHIEF FINANCIAL OFFI.. CHIEF FINANCIAL OFFICER | Feb 22 | Sell | 14.20 | 13,068 | 185,566 | 470,644 | 02/23/23 |
Lish Scott | SVP, DEVELOPMENT SVP, DEVELOPMENT | Feb 21 | Sell | 14.2 | 22,070 | 313,394 | 453,034 | 02/23/23 |
L-5 Healthcare Partners, LLC | - - | Feb 17 | Option | 3.5 | 2,346,032 | 8,211,112 | 13,343,865 | 02/21/23 |
Hunsaker Craig E | EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC | Feb 17 | Sell | 14.04 | 65,716 | 922,653 | 1,472,861 | 02/21/23 |
Hunsaker Craig E | EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC | Feb 17 | Option | 3.5 | 134,921 | 472,224 | 1,570,916 | 02/21/23 |
Hunsaker Craig E | EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC | Feb 09 | Sell | 14 | 60,000 | 840,000 | 1,435,995 | 02/10/23 |
L-5 Healthcare Partners, LLC | - - | Jan 25 | Option | 3.5 | 2,000,000 | 7,000,000 | 11,530,346 | 01/26/23 |
Miles Patrick | CEO CEO | Jan 20 | Sell | 13.16 | 180,000 | 2,368,800 | 5,301,633 | 01/24/23 |
Miles Patrick | CEO CEO | Jan 17 | Sell | 13.23 | 180,000 | 2,381,400 | 5,481,633 | 01/19/23 |
TULLIS JAMES L L | Director Director | Dec 16 | Sell | 10.59 | 50,000 | 529,500 | 497,974 | 12/20/22 |
Sponsel David | EVP, SALES EVP, SALES | Dec 05 | Sell | 9.88 | 10,000 | 98,800 | 556,983 | 12/05/22 |
L-5 Healthcare Partners, LLC | - - | Nov 09 | Option | 3.5 | 1,000,000 | 3,500,000 | 9,242,761 | 11/10/22 |
Sponsel David | EVP, SALES EVP, SALES | Nov 07 | Sell | 9.25 | 10,000 | 92,500 | 566,690 | 11/09/22 |
Mowry David H | Director Director | Aug 29 | Sell | 7.85 | 4,370 | 34,304 | 91,973 | 08/29/22 |
Altman Elizabeth Ann | Director Director | Aug 17 | Sell | 9.06 | 8,009 | 72,562 | 40,431 | 08/17/22 |
Hunsaker Craig E | EVP, PEOPLE/CULTURE.. EVP, PEOPLE/CULTURE & GC | Aug 15 | Sell | 9.42 | 40,795 | 384,289 | 1,251,174 | 08/17/22 |
Pritzker Jennifer N. | 10% Owner 10% Owner | Aug 09 | Buy | 7.99 | 8,100 | 64,719 | 6,000 | 08/11/22 |
Snider Brian | EVP, Marketing EVP, Marketing | Jun 15 | Option | 2 | 50,000 | 100,000 | 676,821 | 06/17/22 |
Segal Paul | 10% Owner 10% Owner | Jun 14 | Buy | 6.91 | 100,000 | 691,000 | 338,825 | 06/16/22 |
Hunsaker Craig E | EVP, People/Culture.. EVP, People/Culture & GC | Jun 13 | Sell | 7.16 | 60,000 | 429,600 | 1,301,729 | 06/15/22 |
TULLIS JAMES L L | Director Director | Jun 13 | Buy | 6.76 | 7,500 | 50,700 | 187,558 | 06/15/22 |
Berkowitz Mortimer III | Director Director | Jun 09 | Buy | 7.20 | 16,000 | 115,200 | 555,121 | 06/13/22 |
Segal Paul | 10% Owner 10% Owner | Jun 09 | Buy | 7.14 | 71,329 | 509,289 | 238,825 | 06/13/22 |